Outlook Therapeutics, Inc.

OTLK · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
256
SEC Filings

Business Summary

PART I Overview We are a biopharmaceutical company that has developed ONS-5010/LYTENAVA TM as the first ophthalmic formulation of bevacizumab approved by the European Commission in the European Union, or EU, and the Medicines and Healthcare products Regulatory Agency, or MHRA, in the United Kingdom, or UK, for use in adults for the treatment of wet age-related macular degeneration, or wet AMD. In June 2025, we launched directly into the initial markets of Germany and the UK. Additionally, our Bi...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOTLKdiscussed_in_filing Cybersecurity
topic_mentionOTLKdiscussed_in_filing Trusted Computing
topic_mentionOTLKdiscussed_in_filing Blockchain & Crypto
topic_mentionOTLKdiscussed_in_filing Regulation
topic_mentionOTLKdiscussed_in_filing Healthcare & Bio
topic_mentionOTLKdiscussed_in_filing Sovereign & Government
topic_mentionOTLKdiscussed_in_filing Cybersecurity
topic_mentionOTLKdiscussed_in_filing Trusted Computing
topic_mentionOTLKdiscussed_in_filing Blockchain & Crypto
topic_mentionOTLKdiscussed_in_filing Regulation
topic_mentionOTLKdiscussed_in_filing Healthcare & Bio
topic_mentionOTLKdiscussed_in_filing Sovereign & Government
topic_mentionOTLKdiscussed_in_filing Cybersecurity
topic_mentionOTLKdiscussed_in_filing Trusted Computing
topic_mentionOTLKdiscussed_in_filing Blockchain & Crypto
topic_mentionOTLKdiscussed_in_filing Regulation
topic_mentionOTLKdiscussed_in_filing Healthcare & Bio
topic_mentionOTLKdiscussed_in_filing Sovereign & Government
topic_mentionOTLKdiscussed_in_filing Cybersecurity
topic_mentionOTLKdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-192025-09-300001104659-25-123264EDGAR98K words
2024-12-272024-09-300001558370-24-016491EDGAR—
2023-12-222023-09-300001558370-23-020000EDGAR—
2022-12-292022-09-300001558370-22-019036EDGAR—
2021-12-232021-09-300001558370-21-017007EDGAR—
2020-12-232020-09-300001558370-20-014540EDGAR—
2019-12-192019-09-300001104659-19-074095EDGAR—
2018-12-182018-09-300001144204-18-065142EDGAR—
2017-12-292017-09-300001571049-17-008779EDGAR—
2016-12-292016-09-300001571049-16-020882EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001104659-26-016554EDGAR23K words
2025-08-142025-06-300001558370-25-011588EDGAR—
2025-05-152025-03-310001558370-25-007873EDGAR—
2025-02-142024-12-310001558370-25-001022EDGAR—
2024-08-142024-06-300001558370-24-012234EDGAR—
2024-05-152024-03-310001558370-24-008318EDGAR—
2024-02-142023-12-310001558370-24-001172EDGAR—
2023-08-142023-06-300001558370-23-014866EDGAR—
2023-05-152023-03-310001558370-23-009942EDGAR—
2023-02-142022-12-310001558370-23-001286EDGAR—
2022-08-102022-06-300001558370-22-013086EDGAR—
2022-05-132022-03-310001558370-22-008780EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001104659-26-034601EDGAR21K words
2026-03-160001104659-26-028103EDGAR—
2026-03-110001104659-26-026465EDGAR—
2026-03-100001104659-26-025893EDGAR—
2026-03-050001104659-26-024189EDGAR—
2026-02-180001104659-26-017118EDGAR—
2026-02-170001104659-26-015887EDGAR—
2026-02-110001104659-26-013470EDGAR—
2026-01-020001104659-26-000066EDGAR—
2025-12-190001104659-25-122786EDGAR—

256 total filings indexed. 224 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001649989
TickerOTLK
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0a4ece59a73d7d09c8b25e4f689d47136b563466343d49ac04f5e04fe72ccd33
parent: 3a66b15f367a38f86db4cb5c1937b898c40153f2e2330874fbe3700fb80663e5
content hash: 0684452e094262c077b3691e639bd67c2dc050e91dda3c47be925a322c01ea05
signed: 2026-04-13T04:46:46.655Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf